Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 infection and vaccination are linked to hair loss, especially in women and those with nutritional deficiencies.

Public interest in skin issues changed during COVID-19, with more focus on dry skin, hair problems, and hand eczema.

The ACE1 gene variant doesn't affect long-COVID symptoms.

Higher oxidative stress markers are linked to hair loss in post-COVID-19 patients.

Monocytes might be linked to hair loss after COVID-19.

Eating plant-based anti-inflammatories and antioxidants may help manage long-term COVID-19 health issues.

Post-COVID-19 patients are at risk for hair loss.

Vaccination helps reduce long COVID symptoms in women with PCOS.

Long COVID causes various long-term health issues and needs better awareness and treatment.

The COVID-19 pandemic has increased hair loss and psychological distress in women.

COVID-19 symptoms range from mild to severe, with older adults at higher risk.

Skin symptoms like rashes and sores can indicate COVID-19 severity, especially in older people.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

Many COVID-19 survivors experience long-term symptoms like fatigue and sleep issues, needing ongoing medical support.

Recognizing skin symptoms can help diagnose and manage COVID-19.

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

A woman's complete hair loss condition improved after recovering from COVID-19.

Skin symptoms appear in up to 20% of Covid-19 cases.

Removing breast implants resolved the patient's symptoms.

Certain symptoms and patient profiles, like thoracic pain and general malaise, increase the risk of COVID-19 patients being readmitted to the emergency department.

Epipharyngeal Abrasive Therapy helps reduce symptoms in Long COVID patients with chronic epipharyngitis.

Proper management of PTSD with psychotherapy and medication can reduce symptoms.

Long COVID recovery is hindered by smoking, with hair loss being a difficult symptom to treat.

Many doctors lack knowledge about COVID-19 skin symptoms and need better education and guidelines.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Many recovered COVID-19 patients, especially women, experience lingering symptoms like fatigue and headaches.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

Women, younger age, and low BMI increase the risk of long COVID symptoms.

Long COVID symptoms are linked to immune issues, poor blood flow, and lung problems.

Most COVID-19 patients had lingering symptoms 60 days after leaving the hospital.